Hyundai ADM Bio Inc. (KOSDAQ: 187660)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,314.00
-73.00 (-5.26%)
Dec 20, 2024, 9:00 AM KST
38.10%
Market Cap 55.59B
Revenue (ttm) 10.35B
Net Income (ttm) -18.63B
Shares Out 42.31M
EPS (ttm) -440.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 266,416
Open 1,387.00
Previous Close 1,387.00
Day's Range 1,310.00 - 1,399.00
52-Week Range 938.00 - 1,985.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 17, 2025

About Hyundai ADM Bio

Hyundai ADM Bio Inc., a contract research organization, provides clinical services in Asia. It offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs. The company also provides pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance; and quality assurance services. In addition, it develops, manufactures, and sells med... [Read more]

Industry Commercial Physical and Biological Research
Founded 2003
Employees 160
Stock Exchange KOSDAQ
Ticker Symbol 187660
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.